PlainPharmaWatch

CMS Open Payments · Program Year 2024

Gilead Sciences, Inc.

Gilead Sciences, Inc. reported $72,668,586.58 in payments to 118,932 physicians and teaching hospitals across 121,377 transactions.

See the rankings → How this is sourced
$72.7M
Total payments
121,377
Transactions
118,932
Recipients
+$3.5M
General Payments vs PY2023

Gilead Sciences, Inc. reported $72,668,586.58 in payments to 118,932 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #39 of 1,925 reporting manufacturers (0.5% of all US industry payments), averaging $611.01 per recipient across 8 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Gilead Sciences, Inc. pairs top-5% payment volume with an unusually diversified payment pattern across a wide recipient base.

#39
of 1,925 companies
0.5%
of all US industry payments
0.1%
paid to its single top recipient
8
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Gilead Sciences, Inc.'s CMS-reported General Payments increased by $3.5M (+9.8%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: GILEAD SCIENCES, INC.PY2023: GILEAD SCIENCES, INC.PY2024: Gilead Sciences, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$36.1MPY2024$39.6M
PY2023
$36,066,155.66
PY2024
$39,607,599.13

How Gilead Sciences, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Gilead Sciences, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$72,668,587 Top 2% higher than 98% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). Below this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Below this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Below this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Below this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). This entry sits in this band. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Gilead Sciences, Inc.

Rank #39 of 1,925 companies in CMS Open Payments for 2024 belongs to Gilead Sciences, Inc., which reported $72,668,586.58 across 121,377 transactions to 118,932 recipients - representing 0.5% of all industry payments reported nationwide for the year. Averages work out to $598.70 per transaction and $611.01 per recipient.

"Grant" leads the 8-category general-payment breakdown below at $15.7M (21.6% of the company's reported total, 196 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

Gilead Sciences, Inc. made 8 types of general payments. "Grant" is the largest category at $15.7M, 21.6% of the company's reported total.

How Gilead Sciences, Inc. divides its payments

General-payment categories, ordered by reported total

1. Grant$15.7M2. Compensation for Services…$10.6M3. Consulting Fee$5.4M4. Food and Beverage$3.6M5. Travel and Lodging$2.5M6. Royalty or License$1.1M7. Space Rental or Facility …$588.8K8. Education$32.6K
Payment Type Amount Transactions
Grant $15.7M 196
Compensation for Services Other Than Consulting $10.6M 4,256
Consulting Fee $5.4M 1,169
Food and Beverage $3.6M 106,181
Travel and Lodging $2.5M 6,561
Royalty or License $1.1M 11
Space Rental or Facility Fees $588.8K 163
Education $32.6K 395

Recipient Concentration in General Payments

The five largest recipient relationships account for $8,252,580.49 (20.8%) of $39,607,599.13 in this company's General Payments records across 30,271 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Gilead Sciences, Inc.

The five named recipients with the highest reported General Payments from this company

Emory University Hospital$4.3MOchsner Clinic Foundation$1.5MUniversity Of Washington Med…$1.2MPh Patewood Hospital$701.3KHackensack University Medica…$613.8K
  1. 1

    Emory University Hospital

    $4,269,910.88 across 21 reported transactions

  2. 2

    Ochsner Clinic Foundation

    $1,465,691.70 across 25 reported transactions

  3. 3

    University Of Washington Med Ctr

    $1,201,838.91 across 17 reported transactions

  4. 4

    Ph Patewood Hospital

    $701,326.00 across 6 reported transactions

  5. 5

    Hackensack University Medical Center

    $613,813.00 across 6 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $598.70. Average per recipient: $611.01.

Total Amount

$72,668,586.58

Avg per Transaction

$598.70

Avg per Recipient

$611.01

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Gilead Sciences, Inc. Share

0.5%

#39 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Gilead Sciences, Inc.

Intuitive Surgical, Inc.

$74.7M 126,596 recipients

Innovation Technologies Inc

$75.8M 3,361 recipients

BeiGene, Ltd.

$77.4M 57 recipients

Teva Pharmaceuticals USA, Inc.

$67.4M 141,158 recipients

Advanced Accelerator Applications

$63.9M 167 recipients

Servier BioInnovation

$83.4M 11 recipients

Frequently Asked Questions

How much did Gilead Sciences, Inc. pay to physicians and hospitals in 2024? ▾
In Program Year 2024, CMS Open Payments recorded $72,668,586.58 from Gilead Sciences, Inc. to physicians and hospitals across 121,377 transactions - 0.5% of all industry payments reported that year.
How many physicians received payments from Gilead Sciences, Inc.? ▾
Gilead Sciences, Inc. made payments to 118,932 physicians and teaching hospitals in 2024. The average payment per recipient was $611.01.
What types of payments did Gilead Sciences, Inc. make? ▾
Gilead Sciences, Inc. made 8 different types of general payments (consulting, meals, travel, and similar categories). The largest general-payment category was "Grant" at $15.7M, representing 21.6% of the company's reported total.
How does Gilead Sciences, Inc. rank among pharmaceutical companies? ▾
By total payment amount, Gilead Sciences, Inc. sits at #39 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Gilead Sciences, Inc.? ▾
The average transaction from Gilead Sciences, Inc. was $598.70 in 2024. The company made 121,377 total transactions to 118,932 recipients.
Where does the payment data for Gilead Sciences, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Gilead Sciences, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.